Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-04-19
- Last Posted Date
- 2024-08-28
- Target Recruit Count
- 15
- Registration Number
- NCT05334693
- Locations
- 🇧🇾
Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Minsk Region, Belarus
Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-04-18
- Last Posted Date
- 2024-08-28
- Target Recruit Count
- 10
- Registration Number
- NCT05333302
- Locations
- 🇧🇾
Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Minsk Region, Belarus
Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML
- First Posted Date
- 2022-03-09
- Last Posted Date
- 2024-08-28
- Target Recruit Count
- 15
- Registration Number
- NCT05272293
- Locations
- 🇧🇾
Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Minsk Region, Belarus
Safety of Expanded Haploidentical Natural Killer Cells for Leukemia
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-03-30
- Last Posted Date
- 2022-03-02
- Target Recruit Count
- 10
- Registration Number
- NCT04327037
- Locations
- 🇧🇾
Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Minsk Region, Belarus
DNA Vaccination Against Neuroblastoma
Early Phase 1
- Conditions
- Interventions
- First Posted Date
- 2019-08-08
- Last Posted Date
- 2022-03-02
- Target Recruit Count
- 12
- Registration Number
- NCT04049864
- Locations
- 🇧🇾
Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Minsk Region, Belarus
© Copyright 2024. All Rights Reserved by MedPath